Lipopeptide delivery of siRNA to the central nervous system

5Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

RNA interference is a relatively new tool used to silence speci fi c genes in diverse biological systems. The development of this promising new technique for research and therapeutic use in studying and treating neurological diseases has been hampered by the lack of an ef fi cient way to deliver siRNA transvascularly across the blood-brain barrier (BBB) to the central nervous system (CNS). Here we describe a method for delivering siRNA to the CNS by complexing it to a peptide that acts as a neuronal address by binding to acetylcholine receptors (AchRs). Adding cationic liposomes to the complex protects it from serum nucleases and proteases en route. When injected intravenously, these liposome-siRNA-peptide complexes resist serum degradation, effectively cross the BBB, and deliver siRNA to AchR-expressing cells to suppress protein expression in the CNS. © Springer Science+Business Media, LLC 2013.

Cite

CITATION STYLE

APA

Zabel, M. D. (2013). Lipopeptide delivery of siRNA to the central nervous system. Methods in Molecular Biology, 948, 251–262. https://doi.org/10.1007/978-1-62703-140-0_17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free